Toni Stifano, Office of Compliance, Promotion and Advertising Policy Staff, CDRH, FDA

Bryant Godfrey, J.D., M.H.A., Senior Lead Regulatory Counsel, Office of Prescription Drug Promotion, FDA

Cynthia Ng, JD, Regulatory Counsel, FDA

Janet L. "Lucy" Rose, MBA, President, Lucy Rose and Associates, LLC

Paul J. Savidge, JD, MBA, Vice President & Associate General Counsel,, Regulatory/Commercial Law, Bristol-Myers Squibb Co.

Michele Sharp, PharmD, Senior Director, Global Regulatory Affairs – US, Eli Lilly and Company

Thomas W. Abrams, MBA, RPh, Director, Office of Prescription Drug Promotion, CDER, FDA

Lisa L. Stockbridge, PhD, Branch Chief, Advertising and Promotional Labeling Branch,CBER, FDA

Dale Cooke, Introduction/Discussion, Vice President/Group Director, Regulatory Review, Digitas Health

Edwin J Tucker, BSc, MB, ChB, DPM, MRCP, MBA, VP, Head of PV Operations, Global Medical Safety, Janssen Research & Development

Leah Palmer, PharmD, Executive Director, Regulatory Promotions, Amgen Inc.

Amy Smith, Worldwide Director, Regulatory Affairs, Life Scan, Inc.

Dan J. Halberstadt, RPh, Senior Director, US Medical Communications & Knowledge Management, Global Medical Affairs, Shire SP

Kinsey S .Reagan, Esq. Partner, Kleinfeld, Kaplan and Becker, LLP

Deborah Wolf, JD, Regulatory Counsel, Offi ce of Compliance, CDRH, FDA

Zafar Toor, PharmD, Director, Commercial Regulatory Affairs, Regulatory Core Functional Unit, Eisai Product Creation Systems

William A. Sarraille, Partner , Sidley Austin, LLP

Kris Curry, Vice President, Health Care Compliance, Pharmaceuticals Group, Johnson & Johnson

Robert J. Matheis, PhD, Senior Director, CER Communications, Evidence Based Medicine Sanofi

Michael S. Labson, JD, Partner, Covington & Burling LLP

Glenn N. Byrd, MBA, RAC, Senior Director, Regulatory Affairs, MedImmune, LLC

Bryant Lim, JD, Associate General Counsel, ViroPharma Incorporated